NCT06282159 - A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 23, 2024

Primary Completion Date

July 28, 2025

Study Completion Date

August 31, 2027

Conditions

Myasthenia Gravis, Generalized

Interventions

DRUG

DNTH103

Day 1: IV loading dose Week 1 to Week 11: DNTH103 administered SC every 2 weeks

DRUG

Placebo

Day 1: IV infusion of placebo Week 1 to Week 11: placebo administered SC every 2 weeks

Trial Locations (56)

1000

Clinical Study Site, Skopje

2000

Clinical Study Site, Rosario

5021

Clinical Study Site, Bergen

11000

Clinical Study Site, Belgrade

13100

Clinical Study Site, Safed

18000

Clinical Study Site, Niš

20133

Clinical Study Site, Milan

21000

Clinical Study Site, Novi Sad

23219

Clinical Study Site, Richmond

32751

Clinical Study Site, Maitland

33076

Clinical Study Site, Bordeaux

33487

Clinical Study Site, Boca Raton

33620

Clincal Study Site, Tampa

34000

Clinical Study Site, Kragujevac

34205

Clinical Study Site, Bradenton

40123

Clinical Study Site, Katowice

40503

Clinical Study Site, Lexington

43221

Clinical Study Site, Columbus

45219

Clinical Study Site, Cincinnati

48824

Clinical Study Site, East Lansing

56126

Clinical Study Site, Pisa

62269

Clinical Study Site, O'Fallon

65212

Clinical Study Site, Columbia

66103

Clinical Study Site, Kansas City

67000

Clinical Study Site, Strasbourg

70852

Clinical Study Site, Ostrava

75206

Clinical Study Site, Dallas

75243

Clinical Study Site, Dallas

77030

Clinical Study Site #2, Houston

Clinical Study Site, Houston

79414

Clinical Study Site, Lubbock

80131

Clinical Study Site, Napoli

85028

Clinical Study Site, Phoenix

92868

Clinical Study Site, Irvine

3109601

Clinical Study Site, Haifa

06905

Clinical Study Site, Stamford

02215

Clinical Study Site, Boston

T4000

Clinical Study Site, San Miguel de Tucumán

20/11/1902

Clinical Study Site, Buenos Aires

C1012AAR

Clinical Study Site, Buenos Aires

C1015ABR

Clinical Study Site, Buenos Aires

X5004CDT

Clinical Study Site, Córdoba

N6A 5W9

Clinical Study Site, London

02100

Clinical Study Site, Copenhagen

06001

Clinical Study Site, Nice

Unknown

Clinical Study Site, Ramat Gan

Clinical Study Site, Amsterdam

Clinical Study Site, Malmo

00168

Clinical Study Site, Rome

00189

Clinical Study Site, Rome

85-065

Clinical Study Site, Bydgoszcz

31-202

Clinical Study Site, Krakow

31-503

Clinical Study Site, Krakow

20-093

Clinical Study Site, Lublin

01-684

Clinical Study Site, Warsaw

02-657

Clinical Study Site, Warsaw